[go: up one dir, main page]

NO895307D0 - FILLED MICROCAPLES. - Google Patents

FILLED MICROCAPLES.

Info

Publication number
NO895307D0
NO895307D0 NO895307A NO895307A NO895307D0 NO 895307 D0 NO895307 D0 NO 895307D0 NO 895307 A NO895307 A NO 895307A NO 895307 A NO895307 A NO 895307A NO 895307 D0 NO895307 D0 NO 895307D0
Authority
NO
Norway
Prior art keywords
microgranules
microcaples
filled
abovementioned
skin
Prior art date
Application number
NO895307A
Other languages
Norwegian (no)
Other versions
NO895307L (en
Inventor
Jean-Claude Jamoulle
Josiane Allec
Alain Brzokenwicz
Braham Shroot
Original Assignee
Cird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird filed Critical Cird
Publication of NO895307D0 publication Critical patent/NO895307D0/en
Publication of NO895307L publication Critical patent/NO895307L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Microgranules loaded with a substance which is therapeutically active with respect to skin disorders and which melts on application to the skin. They are essentially formed by granulation of the abovementioned active substance using at least one saturated fatty acid triglyceride having a melting point of between 30 and 50 DEG C, the abovementioned microgranules having an average diameter of between approximately 5 mu m and 800 mu m. These microgranules find application in the treatment of skin disorders.
NO89895307A 1988-12-29 1989-12-28 FILLED MICROCAPLES. NO895307L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU87416A LU87416A1 (en) 1988-12-29 1988-12-29 MICROGRANULES LOADED WITH AN ACTIVE SUBSTANCE, ESSENTIALLY CONSISTING OF A TRIGLYCERIDE OF SATURATED FATTY ACIDS AND THEIR TOPICAL USE IN THE THERAPEUTIC FIELD

Publications (2)

Publication Number Publication Date
NO895307D0 true NO895307D0 (en) 1989-12-28
NO895307L NO895307L (en) 1990-07-02

Family

ID=19731128

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89895307A NO895307L (en) 1988-12-29 1989-12-28 FILLED MICROCAPLES.

Country Status (16)

Country Link
EP (1) EP0376852B1 (en)
JP (1) JP2731008B2 (en)
KR (1) KR900009058A (en)
AT (1) ATE90869T1 (en)
AU (1) AU617570B2 (en)
CA (1) CA2006834A1 (en)
DE (2) DE68907335T2 (en)
DK (1) DK669789A (en)
ES (1) ES2034951T3 (en)
FI (1) FI896321A0 (en)
GR (1) GR910300044T1 (en)
LU (1) LU87416A1 (en)
NO (1) NO895307L (en)
NZ (1) NZ231982A (en)
PT (1) PT92747A (en)
ZA (1) ZA899961B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649608B1 (en) * 1989-07-12 1991-10-11 Oreal COSMETIC COMPOSITION IN THE FORM OF AN AQUEOUS GEL CONTAINING SUSPENSION SPHEROIDS OF A NON-HYDROPHILIC SOLID LIPID SUBSTANCE
DE4336407A1 (en) * 1993-10-21 1995-04-27 Rotring Int Gmbh Waterproof cosmetics
FR2721210B1 (en) * 1994-06-17 1996-08-02 Oreal Cleaning composition containing lipid grains.
US5540920A (en) * 1994-11-22 1996-07-30 Olin Corporation Synergistic biocide composition containing pyrithione plus an additive
US5679648A (en) * 1994-11-30 1997-10-21 The University Hospital Methods for the treatment and prevention of fungal infections by administration of 3'-deoxypurine nucleosides
AT408067B (en) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION AND METHOD FOR THE PRODUCTION THEREOF
DE19511322C2 (en) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile eye gels containing medium chain triglycerides and process for their preparation
FR2737668B1 (en) * 1995-08-08 1997-10-31 Rocher Yves Biolog Vegetale BALLS BASED ON LIPOPHILIC SUBSTANCES, THEIR MANUFACTURING METHOD AND THEIR APPLICATIONS
JPH09268118A (en) * 1996-04-01 1997-10-14 Kao Corp Skin color-improving beautifier
DE19738247C2 (en) * 1997-09-02 2000-02-17 Goldwell Gmbh Hair care products
DE19952790A1 (en) * 1999-11-03 2001-05-17 Cognis Deutschland Gmbh Process for the production of fat granules
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
ITMI20012366A1 (en) * 2001-11-09 2003-05-09 Farmatron Ltd THERAPEUTIC SYSTEMS STABILIZED WITH IMMEDIATE RELEASE AND / OR MODIFIED FOR THE ORAL ADMINISTRATION OF ACTIVE AND / OR EXCIPIENT PRINCIPLES AND / OR WINGS
WO2003092784A1 (en) 2002-05-06 2003-11-13 Vectura Limited Application device for topical administration of pharmaceutical agents
US8980235B2 (en) * 2003-09-30 2015-03-17 Arch Chemicals, Inc. Coated metal pyrithione particles for treatment of microorganisms
WO2013063067A1 (en) * 2011-10-24 2013-05-02 Stable Solutions Llc Enriched injectable emulsion containing selected fatty acid triglycerides
FR3075635B1 (en) * 2017-12-22 2019-12-06 Lvmh Recherche PROCESS FOR THE PREPARATION OF ANHYDROUS SPHEROIDS BY CRYOGENIA
KR102446371B1 (en) * 2019-06-11 2022-09-22 대봉엘에스 주식회사 Lipid composition and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB543309A (en) * 1940-12-04 1942-02-19 John David Evans Improvements in or relating to drugs
DE2309202A1 (en) * 1973-02-21 1974-08-29 Schering Ag MEDICINAL FORMS WITH MICRO-ENCAPSULATED MEDICINAL ACTIVE
DE2725924C3 (en) * 1977-06-08 1980-11-06 Hobeg Hochtemperaturreaktor-Brennelement Gmbh, 6450 Hanau Process for the production of spherical particles from low-melting organic substances

Also Published As

Publication number Publication date
EP0376852B1 (en) 1993-06-23
AU617570B2 (en) 1991-11-28
NZ231982A (en) 1991-03-26
ATE90869T1 (en) 1993-07-15
CA2006834A1 (en) 1990-06-29
DK669789D0 (en) 1989-12-28
JPH02300116A (en) 1990-12-12
NO895307L (en) 1990-07-02
AU4730689A (en) 1990-07-05
GR910300044T1 (en) 1991-11-15
DE68907335T2 (en) 1994-01-13
EP0376852A1 (en) 1990-07-04
ES2034951T3 (en) 1994-10-16
FI896321A0 (en) 1989-12-28
LU87416A1 (en) 1990-07-10
PT92747A (en) 1990-06-29
JP2731008B2 (en) 1998-03-25
ZA899961B (en) 1990-10-31
ES2034951T1 (en) 1993-04-16
KR900009058A (en) 1990-07-02
DE376852T1 (en) 1991-07-04
DK669789A (en) 1990-06-30
DE68907335D1 (en) 1993-07-29

Similar Documents

Publication Publication Date Title
NO895307D0 (en) FILLED MICROCAPLES.
PT85055A (en) METHOD FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING LEVODOPA METHYL ESTER
HUT50624A (en) Process for producing pharmaceuical compositions with controlled release of active ingredient
NO162965C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALFA- (2-OXO-2,4,5,6,7,7A-HEXSAHYDROTIENO- (3,2-C) -5-PYRIDYL) -PHENYL-ACETIC ACID DERIVATIVES.
DK415689A (en) PHARMACEUTICAL AGENTS
NO170081C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLD DERIVATIVES WITH ACTIVITY ON COLLINERY SYSTEM
DE69705963D1 (en) CRYSTALIZING TRIGLYCERIDE FAT
ES2045120T4 (en) METHOD FOR PREPARING A MEDICATION FOR THE TREATMENT OR PREVENTION OF LOSS OF MEMORY.
NO165071C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 7- (3-AMINO-1-PYRROLIDINYL) -8-CHLORO-1-CYCLOPROPYL-6-FLUORO-1,4, -DIHYDRO-4-OXO-3-CHINOLINE-CARBOXYL.
MC1991A1 (en) PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACID ESTERS
OA05647A (en) New esters of cyclopropanecarboxylic acids, their preparation and application to the control of parasites.
NO891114D0 (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARAKIDONIC ACID DERIVATIVES.
NO171211C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANES
FR2315490A1 (en) RACEMIZATION OF OPTICALLY ACTIVE 2,2-DIMETHYL-3- (2,2-DICHLOROVINYL) -CYCLOPROPANE-CARBOXYL ACID AND ITS DERIVATIVES
NO164243C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE 16,17-ACETALS-SUBSTITUTED PREGNAN-21-ACETIC ACID DERIVATIVES
IL61418A (en) Fluorine-substituted benzyl esters of 2,2,3,3-tetramethyl cyclopropane-1-carboxylic acid,their preparation and their use as pesticides
IT8021037A0 (en) INSECTICIDE COMPOSITIONS WHICH ACID SUBSTITUTED ESTERS CONTAIN THE SAME AS CYCLOPROPANCARBOXYL AND ACTIVE INGREDIENT.
NO168825C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-PYRROLIDINYLTIO-1-AZABICYCLO (3.2.0) HEPT-2-EN-2 CARBOXYLIC ACID DERIVATIVES
NO166322C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE NITROAPOVINCAMIC ACID DERIVATIVES.
NO171499C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5,6-DIHYDRO-4H-CYCLO-PENTA (B) THIOFEN-6-CARBOXYLIC ACID DERIVATIVES
NO863005D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4,5,6,7,8-HEXSAHYDRO-2-ALKYL-4-ARYL-5-OXO-1,7-NAFTYRIDINE-3-CARBOXYL ACID ESTER DERIVATIVES.
SE8405611D0 (en) PROCESS FOR STABILIZATION OF BACAMPICILLIN HYDROCHLORIDE
NO165396C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDINE-5 CARBOXYLIC ACID ESTERS.
BE860687A (en) NEW ESTERS OF ALIPHATIC CARBOXYLIC ACIDS, THEIR PREPARATION AND THEIR APPLICATION FOR THE CONTROL OF PARASITES
PT87077A (en) TERC-BUTYLAMINO-3- (PHENYL-2: -PHENOXY) -1-PROPANOL-2 AND ITS ACID ADDITION SALTS FOR USE AS AN ACTIVE THERAPEUTIC SUBSTANCE